Position history for BlackRock, Inc.'s holdings in THERAVANCE BIOPHARMA INC
BlackRock, Inc. holds 4.3M shares of TBPH (THERAVANCE BIOPHARMA INC), worth $69.7M as of 2026-Q1. The position was increased (+6.1% shares). TBPH represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$69.7M
Current Shares
4.3M
Total Value Change
+$34.8M
Total Shares Change
+583,987
Other major holders of TBPH: BAUPOST GROUP LLC/MA
Increased |
| 4.3M |
+6.1% |
| $69.7M |
| 0.0% |
| $13.96 |
31 |
| 2025-Q4 | Decreased | 4.1M | -0.5% | $75.8M | 0.0% | $18.91 | 0 |
| 2025-Q3 | Decreased | 4.1M | -1.7% | $59.4M | 0.0% | $14.43 | 0 |
| 2025-Q2 | Increased | 4.1M | +19.9% | $45.7M | 0.0% | $11.22 | 35 |
| 2025-Q1 | Decreased | 3.5M | -7.0% | $30.8M | 0.0% | $9.23 | 0 |
| 2024-Q4 | New | 3.7M | - | $34.9M | 0.0% | $9.47 | 40 |